WS6.4 Long-term safety and efficacy of ivacaftor in subjects with cystic fibrosis who have the G551D-CFTR Mutation

WS6.2 Anti-inflammatory pulmonal therapy of CF patients with amitriptyline and placebo − a randomised, double-blind, placebo-controlled Phase IIb multicenter cohort study C. Adams1, J.G. Mainz2, L. Naehrlich3, C. Engel4, G. Herrmann4, V. Icheva4, U. Graepler-Mainka4, S. Heyder5, M. Stern4, G. Doring6, E. Gulbins1, J. Riethmueller4. 1University of Duisburg-Essen, Dept. of Molecular Biology, Essen, Germany; 2University of Jena, Childrens Hospital, Jena, Germany; 3University of Giessen, Childrens Hospital, Giessen, Germany; 4University of Tubingen, Childrens Hospital, Tubingen, Germany; 5Klinik Schillerhohe, Gerlingen, Germany; 6University of Tubingen, Tubingen, Germany